Hochschulschrift
Redirecting oncolytic adenovirus-specific T cells by a tumor-specific T cell receptor for therapy of solid tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
107 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Hannover Medical School, Dissertation, 2015
- Klassifikation
-
Medizin, Gesundheit
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:41 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Investigating tumor cell-specific barriers for immunotherapy
Tumor specific gene expression by a replication activated adenovirus vector
Suppression of tumor-specific immunity by Foxp3+ regulatory T cells
Tumor specific transplantation antigen
Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells
Antigen-specific redirection of immune effector cells against GD2-expressing tumors
Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
Identification of neoantigen-specific T-cell responses in diverse rare tumor entities
Human Adenovirus-Specific γ/δ and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation
EMT-specific circulating micro RNAs and circulating tumor cells in metastatic breast cancer
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Investigating tumor cell-specific barriers for immunotherapy
Tumor specific gene expression by a replication activated adenovirus vector
Suppression of tumor-specific immunity by Foxp3+ regulatory T cells
Tumor specific transplantation antigen
Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells
Antigen-specific redirection of immune effector cells against GD2-expressing tumors
Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
Identification of neoantigen-specific T-cell responses in diverse rare tumor entities
Human Adenovirus-Specific γ/δ and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation
EMT-specific circulating micro RNAs and circulating tumor cells in metastatic breast cancer
Immunotherapy with tumor antigen-specific T-cells in ret transgenic mouse melanoma model
Investigating tumor cell-specific barriers for immunotherapy
Tumor specific gene expression by a replication activated adenovirus vector
Suppression of tumor-specific immunity by Foxp3+ regulatory T cells
Tumor specific transplantation antigen
Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells
Antigen-specific redirection of immune effector cells against GD2-expressing tumors
Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
Identification of neoantigen-specific T-cell responses in diverse rare tumor entities
Human Adenovirus-Specific γ/δ and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation
EMT-specific circulating micro RNAs and circulating tumor cells in metastatic breast cancer